Sonova AG
Stäfa, Canton of Zurich, 8712, Switzerland
NCT Number: NCT02895477
Goal of this study is to determine the benefit of an improved feature on a new hearing aid platform.
To investigate the improvements of this feature is compared on a new and older hearing aid platform. The obtained results will be used for future improvement for this feature. This feature should improve the speech understanding and speech recognition of the hearing aid user.
Looking for future studies?
Notify Me18 year–99 year
All sexes
Interventional
Not applicable
Stäfa, Canton of Zurich, 8712, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: after 2 weeks
Functional gain is to measure the aided threshold (in dB hearing level [HL]) in free field via loudspeaker.
Time frame: after 2
Change of Detection thresholds after 4 weeks hearing instrument wearing time
Time frame: after 8 weeks
Functional gain is to measure the aided threshold (in dB hearing level [HL]) in free field via loudspeaker.
Time frame: after 8 weeks
Change of detection thresholds after 4 weeks hearing instrument wearing time
Time frame: after 6 and 12 weeks
Time frame: after 2, 6, 8 and 12 weeks
Sonova AG
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05219474
Ear Diseases, Hearing Disorders
New York, United States
View Trial DetailsNCT01805167
Ear Diseases, Hearing Disorders
Nice, France
View Trial DetailsNCT05070429
Aging, Ear Diseases
Hagerstown, Maryland, United States
View Trial DetailsNCT07501312
Ear Diseases, Hearing Disorders
Aurora, Illinois, United States
View Trial Details